Sign in to continue:

Monday, April 6th, 2026

Category: us corporate news

Innoviva Reports Strong 2025 Financial Results, FDA Approval of NUZOLVENCE, and Growth Outlook for 2026

Innoviva Reports Q4 and Full Year 2025 Results – Detailed In...

VitaNova Life Sciences Corporation Appoints Steve Niu as Director – SEC 8-K Filing Details

VitaNova Life Sciences Corp. 8-K Filing - Director Appointme...